A study of Sonlicromanol for post-COVID patients
Part of Infections, Lungs & breathing clinical trials.
This trial tests a medicine called Sonlicromanol to see if it helps people with lingering symptoms after a mild case of COVID-19. It is for people who have post-exertional malaise (feeling very tired or worse after activity) and a moderate level of disability.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of post-COVID from a doctor.
- You need to have post-exertional malaise, meaning you feel much worse after even small amounts of activity.
- Your daily function should be at 20-70% of normal, as measured by a standard disability scale.
- Your first COVID-19 infection was mild and did not require a hospital stay.
- You were in good health (fully active) before getting COVID-19.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different treatments for long COVID (PCC) symptoms like fatigue and brain fog that started after a COVID infection. It aims to find which treatments help people recover.
This trial studies people with mild to moderate COVID-19 symptoms to better understand and help “post-COVID” condition (ongoing effects after infection). You may be eligible if you’re an adult with a recent confirmed COVID-19 test and you agreed to take part.
This trial tests a new medicine, sonlicromanol, to see if it can ease chronic fatigue and improve muscle function in people with a specific genetic condition called primary mitochondrial disease. If effective, it could offer a new treatment option to improve daily energy and quality of life.
This trial tests if a low dose of sirolimus, a medicine that calms the immune system, can help people with long COVID. If you have had long COVID symptoms for at least 6 months, like severe fatigue, brain fog, or chest pain, you may be able to join.
This trial tests whether immune-modulating treatments can help people with long covid, especially those with ongoing heart, cough, or fatigue symptoms. It aims to see if calming the immune system reduces symptoms and improves daily life.
This trial tests a natural compound to help reduce long-term inflammation in people who still have symptoms after a COVID-19 infection. If you're struggling with ongoing symptoms like fatigue or brain fog after COVID-19, this might be worth exploring.
Hear when a new Post-COVID Condition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.